FWMMX
Price
$66.28
Change
+$0.23 (+0.35%)
Updated
Nov 19 closing price
Net Assets
203.68B
JHJIX
Price
$24.46
Change
+$0.08 (+0.33%)
Updated
Nov 19 closing price
Net Assets
117.84M
Interact to see
Advertisement

FWMMX vs JHJIX

Header iconFWMMX vs JHJIX Comparison
Open Charts FWMMX vs JHJIXBanner chart's image
American Funds Washington Mutual 529-F-2
Price$66.28
Change+$0.23 (+0.35%)
VolumeN/A
Net Assets203.68B
JHancock ESG Large Cap Core I
Price$24.46
Change+$0.08 (+0.33%)
VolumeN/A
Net Assets117.84M
FWMMX vs JHJIX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FWMMX has more cash in the bank: 204B vs. JHJIX (118M). FWMMX pays higher dividends than JHJIX: FWMMX (1.38) vs JHJIX (0.26). FWMMX was incepted earlier than JHJIX: FWMMX (5 years) vs JHJIX (9 years). JHJIX (1.08) is less costly to investors than FWMMX (0.35). JHJIX (30.00) and FWMMX (29.00) have comparable annual turnover. FWMMX has a lower initial minimum investment than JHJIX: FWMMX (250) vs JHJIX (250000). FWMMX annual gain was more profitable for investors over the last year : 4.55 vs. JHJIX (-4.23). FWMMX return over 5 years is better than : 48.73 vs. JHJIX (45.15).
FWMMXJHJIXFWMMX / JHJIX
Total Expense Ratio0.350.8740%
Annual Report Gross Expense Ratio0.351.0832%
Fund Existence5 years9 years-
Gain YTD8.8717.212123%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets204B118M172,881%
Annual Yield % from dividends1.380.26523%
Returns for 1 year4.55-4.23-108%
Returns for 3 years30.8534.5589%
Returns for 5 years48.7345.15108%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTCAX20.510.08
+0.39%
BNY Mellon Sust US Equity A
MSVMX6.15N/A
N/A
Morgan Stanley Vitality Portfolio C
UOPSX93.08N/A
N/A
ProFunds UltraNASDAQ-100 Svc
VSFSX24.70-0.05
-0.20%
Federated Hermes Clover Small Value R6
JFNCX68.22-0.15
-0.22%
Janus Henderson Global Life Sciences C